Amrize (NYSE:AMRZ) Sets New 1-Year Low – Time to Sell?

Amrize Ltd (NYSE:AMRZ)’s stock price reached a new 52-week low on Wednesday. The company traded as low as $36.46 and last traded at $36.4760, with a volume of 552601 shares. The stock had previously closed at $37.28.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on AMRZ shares. Stephens lowered their price target on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a report on Wednesday, August 12th. Citigroup decreased their price objective on Amrize from $58.00 to $50.00 and set a “buy” rating for the company in a report on Friday, October 2nd. JPMorgan Chase & Co. lowered Amrize from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $57.00 to $52.00 in a report on Wednesday, September 2nd. Deutsche Bank Aktiengesellschaft decreased their price target on Amrize from $64.00 to $56.00 and set a “buy” rating for the company in a report on Wednesday, September 23rd. Finally, Zacks Research cut shares of Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $51.76.

Amrize Trading Down 2.8%

The stock has a market cap of $20.04 billion, a PE ratio of 16.69, a price-to-earnings-growth ratio of 1.31 and a beta of 0.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The company has a 50 day moving average of $43.12 and a two-hundred day moving average of $49.81.

Amrize (NYSE:AMRZ) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Sell-side analysts anticipate that Amrize Ltd will post 2.46 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is 20.28%.

Insider Buying and Selling at Amrize

In related news, CFO Baris Oran purchased 3,000 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the transaction, the chief financial officer directly owned 3,000 shares in the company, valued at approximately $142,140. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mario Gross acquired 3,568 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares in the company, valued at $1,793,401. The trade was a 10.22% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have bought 48,983 shares of company stock valued at $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently bought and sold shares of the company. Pictet Asset Management Holding SA boosted its stake in Amrize by 4.7% during the first quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock worth $283,017,000 after buying an additional 234,731 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Amrize by 3.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock valued at $263,371,000 after acquiring an additional 171,622 shares during the period. Vontobel Holding Ltd. boosted its position in shares of Amrize by 2.3% during the 4th quarter. Vontobel Holding Ltd. now owns 4,598,092 shares of the company’s stock worth $252,450,000 after purchasing an additional 105,511 shares during the period. Barclays PLC increased its holdings in Amrize by 95.4% in the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after purchasing an additional 2,253,431 shares during the last quarter. Finally, First Manhattan CO. LLC. increased its holdings in Amrize by 20.0% in the 4th quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock valued at $218,305,000 after purchasing an additional 672,030 shares during the last quarter.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.